| Literature DB >> 28266605 |
Vincent Bessonneau1, Jennifer Ings2, Mark McMaster2, Richard Smith3, Leslie Bragg4, Mark Servos4, Janusz Pawliszyn1.
Abstract
Loss and/or degradation of small molecules during sampling, sample transportation and storage can adversely impact biological interpretation of metabolomics data. In this study, we performed in vivo sampling using solid-phase microextraction (SPME) in combination with non-targeted liquid chromatography and high-resolution tandem mass spectrometry (LC-MS/MS) to capture the fish tissue exposome using molecular networking analysis, and the results were contrasted with molecular differences obtained with ex vivo SPME sampling. Based on 494 MS/MS spectra comparisons, we demonstrated that in vivo SPME sampling provided better extraction and stabilization of highly reactive molecules, such as 1-oleoyl-sn-glycero-3-phosphocholine and 1-palmitoleoyl-glycero-3-phosphocholine, from fish tissue samples. This sampling approach, that minimizes sample handling and preparation, offers the opportunity to perform longitudinal monitoring of the exposome in biological systems and improve the reliability of exposure-measurement in exposome-wide association studies.Entities:
Mesh:
Year: 2017 PMID: 28266605 PMCID: PMC5339820 DOI: 10.1038/srep44038
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Map of different sites investigated generated from Google. (n.d.).
[Google Maps of fish collection sites in Alberta, Canada]. Map data ©2016 Google. Retrieved September 17, 2016, from https://goo.gl/HBAeBS.
Figure 2Chemical-similarity maps of small molecules (n = 494 with MS/MS spectrum) in fish tissue (Tanimoto coefficient ≥0.7).
Green and blue nodes represent small molecules observed only after in vivo SPME sampling and ex vivo SPME sampling, respectively. Grey nodes represent small molecules detected using both sampling methods. Nodes with red border indicates annotated molecule by matching LC-MS/MS libraries with spectral similarity ≥0.7 Edge represents similarity between MS/MS spectra. Thickness of the edges indicates the level of similarity (the thicker is an edge, the more similar are MS/MS spectra).
Small molecules identified in fish tissue using solid-phase microextraction combined with LC-MS/MS with a Q-Exactive Quadrupole-Orbitrap mass spectrometer.
| Metabolite | Family | Precursor m/z | Precursor adduct | RT (min) | Sample class | Similarity cosine |
|---|---|---|---|---|---|---|
| 4-methoxycinnamic acid | Cinnamic acids | 179.070 | [M + H]+ | 8.48 | G2 | 0.78 |
| Phenoxybenzamine | Phenylmethylamines | 304.147 | [M + H]+ | 6.98 | G2 | 0.82 |
| Nicotinamide | Pyridinecarboxylic acids | 123.055 | [M + H]+ | 0.86 | G2 | 0.83 |
| 1-Oleoyl-sn-glycero-3-phosphocholine | Glycerophosphocholines | 522.355 | [M + H]+ | 7.5 | G2 | 0.87 |
| 1-Palmitoleoyl-glycero-3-phosphocholine | Glycerophosphocholines | 494.324 | [M + H]+ | 6.78 | G2 | 0.70 |
| 4-Chlorophenol | Chlorophenols | 129.010 | [M + H]+ | 0.70 | G1 | 0.74 |
| Hydroxyproline | Carboxylic acids and derivates | 132.065 | [M + H]+ | 0.88 | G1 | 0.83 |
| 6-Hydroxynicotinate | Pyridinecarboxylic acids | 140.034 | [M + H]+ | 0.97 | G1 | 0.78 |
| 2-Heptyl-3-hydroxy 4-quinolone | Quinolones | 260.165 | [M + H]+ | 8.30 | G1 | 0.78 |
| Phenylalanine | Phenylpropanoic acids | 166.087 | [M + H]+ | 1.38 | G1, G2 | 0.96 |
| Tyrosine | Phenylpropanoic acids | 182.081 | [M + H]+ | 0.85 | G1, G2 | 0.97 |
| Deoxycarnitine | Fatty acids and conjugates | 146.118 | [M + H]+ | 0.99 | G1, G2 | 0.99 |
| 1-Hydroxybenzotriazole | Benzotriazoles | 136.049 | [M + H]+ | 0.90 | G1, G2 | 0.70 |
| Creatine | Carboxylic acids and derivates | 132.077 | [M + H]+ | 0.88 | G1, G2 | 0.97 |
| 3-Methylhistidine | Carboxylic acids and derivates | 170.093 | [M + H]+ | 0.92 | G1, G2 | 0.82 |
| Cholesterol | Steroids | 369.352 | [M−H2O + H]+ | 10.1 | G1, G2 | 0.95 |
| Histidine | Carboxylic acids and derivates | 156.078 | [M + H]+ | 0.90 | G1, G2 | 0.99 |
| Tryptophan | Indoles | 205.097 | [M + H]+ | 2.90 | G1, G2 | 0.93 |
| Arginine | Carboxylic acids and derivates | 175.119 | [M + H]+ | 0.94 | G1, G2 | 0.95 |
| 2-amino-2-methylpropanoate | Carboxylic acids and derivates | 106.050 | [M+H]+ | 0.74 | G1, G2 | 0.98 |
| Proline | Carboxylic acids and derivates | 116.071 | [M+H]+ | 0.76 | G1, G2 | 0.87 |
| Betaine | Carboxylic acids and derivates | 118.086 | [M+H]+ | 0.75 | G1, G2 | 0.95 |
| Threonine | Carboxylic acids and derivates | 120.066 | [M+H]+ | 0.74 | G1, G2 | 0.91 |
| L-Glutamine | Carboxylic acids and derivates | 147.076 | [M+H]+ | 1.01 | G1, G2 | 0.95 |
| L-Methionine | Carboxylic acids and derivates | 150.058 | [M+H]+ | 0.84 | G1, G2 | 0.81 |
| Carnitine | Fatty acids and conjugates | 162.112 | [M+H]+ | 0.95 | G1, G2 | 0.94 |
| O-Acetylcarnitine | Fatty acids and conjugates | 204.123 | [M+H]+ | 1.25 | G1, G2 | 0.96 |
| Diethylphthalate | Benzoic acids | 223.096 | [M+H]+ | 6.22 | G1, G2 | 0.90 |
| Inosine | Purine nucleosides | 269.088 | [M+H]+ | 0.80 | G1, G2 | 0.94 |
| Adenosine | Purine nucleosides | 268.103 | [M+H]+ | 0.89 | G1, G2 | 0.97 |
| Guanosine | Purine nucleosides | 284.099 | [M+H]+ | 0.80 | G1, G2 | 0.91 |
| Inosinic acid | Purine nucleotides | 349.054 | [M+H]+ | 0.72 | G1, G2 | 0.88 |
| Desmosterol | Steroids | 385.346 | [M+H]+ | 7.98 | G1, G2 | 0.75 |
| 3β-Hydroxy-5-cholestenal | Steroids | 401.341 | [M+H]+ | 8.88 | G1, G2 | 0.80 |
| sn-Glycero-3-phosphocholine | Glycerophosphocholines | 258.110 | [M+H]+ | 0.70 | G1, G2 | 0.94 |
| 1-Palmitoyl-sn-glycero-3-phosphocholine | Glycerophosphocholines | 496.339 | [M+H]+ | 7.3 | G1, G2 | 0.89 |
| 1-Palmitoyl-sn-glycero-3-phosphocholine | Glycerophosphocholines | 518.322 | [M+Na]+ | 7.3 | G1, G2 | 0.89 |
aCosine similarity value between experimental MS/MS spectrum and MS/MS spectrum from public LC-MS/MS libraries.
G1: ex-vivo SPME sampling; G2: in-vivo SPME sampling.